Ian O. Ellis

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

Differential oestrogen receptor binding is associated with clinical outcome in breast cancer

The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

WHO classification of tumours of the breast

Tumor-Infiltrating CD8⁺Lymphocytes Predict Clinical Outcome in Breast Cancer

Prognostic markers in triple‐negative breast cancer

Basal-Like Breast Cancer: A Critical Review

Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies

The Nottingham prognostic index in primary breast cancer